Effect of the antioxidants alpha-tocopherol acetate and sodium selenite on hepatotoxicity induced by antitubercular drugs in rats

Indian Journal of Physiology and Pharmacology

Volumn 48, Issue 1, 2004, Pages 119-122

  Kothekar, Mudgal Anantrao ^a   Ubaid, Razvi Syed ^a   Jaju, Jugalkishor Bhavarlal ^a   Mateenuddin, M D ^a  

^a SRTR Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ISONIAZID; PLASMA PROTEIN; PYRAZINAMIDE; RIFAMPICIN; SODIUM SELENITE; TUBERCULOSTATIC AGENT;

ANALYSIS OF VARIANCE; ANTIOXIDANT ACTIVITY; BLOOD SAMPLING; BODY SURFACE; CLINICAL TRIAL; HUMAN; LETTER; LIVER FUNCTION; LIVER TOXICITY; LUNG TUBERCULOSIS; NONHUMAN;

ANIMALS; ANTIOXIDANTS; ANTITUBERCULAR AGENTS; FEMALE; HEPATITIS, TOXIC; LIVER; LIVER FUNCTION TESTS; MALE; RATS; SODIUM SELENITE; VITAMIN E;

EID: 0346099490     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)

1. Sodhi CP, Rana S, Attri S, Mehta S, Yaiphei K, Mehta SK. Oxidative hepatic injury of isoniazid - rifampicin in young rats subjected to protein energy malnutrition. Drug Chem Toxicol 1998; 21(3): 305-317.
2. Sodhi CP, Rana S, Mehta S, Vaiphei K, Goel RC, Mehta SK. Study of oxidative stress in rifampicin induced hepatic injury in growing rats with and without protein energy malnutrition. Hum Exp Toxicol 1997; 16: 315-321.
3. Sodhi CP, Rana SV, Mehta SK, Vaiphei K, Attri S, Thakur S et al. Study of oxidative stress in isoniazid induced hepatic injury in young rats with and without protein energy malnutrition. J Biochem Toxicol 1996; 11: 139-146.
4. Shakun NP and Shmnan'ko VV. Anti-oxidant effectiveness in isoniazid induced lesions of liver. Farmakol Toksikol 1986; 49(4): 86-89.
5. Shakun NP, Slivka IuI. The correction of the hepatoxicity of antitubercular preparations with tocopherol acetate and riboxin. Eksp Klin Farmakol 1992; 55(3): 52-54.
6. Ramesh R, Jindal SK, Malik SK, Mehta S. Hepatoxicity with isoniazid and rifampicin combination during treatment of tuberculosis. Ind J Tub 1989; 36: 157-160.
7. Thapa BR. Drug induced liver disease. Pediatrics Today 2001; 4(2): 64-69.
8. Ghosh MN, Fundamentals of experimental pharmacology. Scientific Book Agency, Calcutta, 1984; 155.
9. Reitman S, Frankel S. In vitro determination of transaminase activity in serum. Am J Clin Pathol 1957; 28: 56-60.
10. Doumas BT. Estimation of total protein in serum/plasma by biuret method. Clin Chem Acta 1978; 23: 663.
11. Jendrassik L, Grof P. Quantitative estimation of bilirubin in serum/plasma by Jendrassik and Grof's method. Biochem Z 1938; 29: 81.
12. Kind PRN, King EJ. Estimation of plasma phosphatases by determination of hydrolysed phenol with aminoantipyrine. J Clin Path 1954; 7: 322-326.
13. Davidson CS. Guidelines for detection of hepatotoxicity due to drugs and chemicals. NIH publication, U.S. Department of Health and Education and Welfare NIH U.S.A. 1979.
14. Chatterjee MN and Shinde R. Textbook of Medical Biochemistry. 4th ed., Jaypee Brothers, 2000; 180-88, 562-564.
15. Shakun NL, Blikhar EI. Effect of antioxidants on lipid peroxidation and on liver function in patients with pulmonary tuberculosis. Farmakol Toksikol 1986; 49(5): 112-114.